Jonathan Bernstein

Stories

First in vivo CRISPR therapy nears FDA approval after four-year durability data

Investigator on lonvo-z trial

For people with hereditary angioedema, a swelling attack can close the throat. Standard prevention means frequent injections or daily pills. A single infusion that edits a gene inside the liver has now kept working for four years, according to Intellia Therapeutics.

Updated 1 hour ago